LG LG-V940n, Руководство пользователя

Страница: 102 / 117

100 101
For Your Safety
2. What is the FDA’s role concerning the safety of tablets?
Under the law, the FDA does not review the safety of radiation-emitting consumer
products such as tablets before they can be sold, as it does with new drugs or medical
devices. However, the agency has authority to take action if tablets are shown to emit
Radio Frequency (RF) energy at a level that is hazardous to the user. In such a case, the
FDA could require the manufacturers of tablets to notify users of the health hazard and
to repair, replace, or recall the tablets so that the hazard no longer exists.
Although the existing scientific data does not justify FDA regulatory actions, the FDA has
urged the tablet industry to take a number of steps, including the following:
•
Support needed research into possible biological effects of RF of the type emitted
by tablets;
•
Design tablets in a way that minimizes any RF exposure to the user that is not
necessary for device function; and
•
Cooperate in providing users of tablets with the best possible information on
possible effects of tablet use on human health.
The FDA belongs to an interagency working group of the federal agencies that have
responsibility for different aspects of RF safety to ensure coordinated efforts at the
federal level. The following agencies belong to this working group:
•
National Institute for Occupational Safety and Health
•
Environmental Protection Agency
•
Occupational Safety and Health Administration
•
National Telecommunications and Information Administration
The National Institutes of Health participates in some interagency working group
activities, as well.
The FDA shares regulatory responsibilities for tablets with the Federal Communications
Commission (FCC). All tablets that are sold in the United States must comply with FCC
safety guidelines that limit RF exposure. The FCC relies on the FDA and other health
agencies for safety questions about tablets.